Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2011-3-25
pubmed:abstractText
The objective of this study was to investigate the effect of new 4-maleamic acid and 4-maleamide peptidyl chalcone derivatives against human prostate cancer in vitro and in vivo.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1573-904X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
907-19
pubmed:meshHeading
pubmed-meshheading:21184149-Amides, pubmed-meshheading:21184149-Animals, pubmed-meshheading:21184149-Antineoplastic Agents, pubmed-meshheading:21184149-Cell Adhesion, pubmed-meshheading:21184149-Cell Culture Techniques, pubmed-meshheading:21184149-Cell Cycle, pubmed-meshheading:21184149-Cell Line, Tumor, pubmed-meshheading:21184149-Cell Movement, pubmed-meshheading:21184149-Cell Proliferation, pubmed-meshheading:21184149-Cell Survival, pubmed-meshheading:21184149-Chalcones, pubmed-meshheading:21184149-Chick Embryo, pubmed-meshheading:21184149-Chorioallantoic Membrane, pubmed-meshheading:21184149-Humans, pubmed-meshheading:21184149-Inhibitory Concentration 50, pubmed-meshheading:21184149-Male, pubmed-meshheading:21184149-Maleates, pubmed-meshheading:21184149-Mice, pubmed-meshheading:21184149-Mice, Nude, pubmed-meshheading:21184149-Molecular Structure, pubmed-meshheading:21184149-Neovascularization, Physiologic, pubmed-meshheading:21184149-Prostatic Neoplasms, pubmed-meshheading:21184149-Xenograft Model Antitumor Assays
pubmed:year
2011
pubmed:articleTitle
New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer.
pubmed:affiliation
Department of Urology, University Hospital Charité, Schumannstrasse 20/21, 10117, Berlin, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't